Brooks Moore & Associates’s MetLife MET Stock Holding History

Brooks Moore & Associates’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,460	Closed	-$468K	–	88
2022 Q4	$468K	Hold	6,460	–	–	0.34%	60
2022 Q3	$393K	Hold	6,460	–	–	0.32%	60
2022 Q2	$406K	Hold	6,460	–	–	0.29%	63
2022 Q1	$454K	Hold	6,460	–	–	0.28%	67
2021 Q4	$404K	Hold	6,460	–	–	0.24%	76
2021 Q3	$399K	Hold	6,460	–	–	0.26%	70
2021 Q2	$387K	Hold	6,460	–	–	0.25%	76
2021 Q1	$393K	Hold	6,460	–	–	0.27%	74
2020 Q4	$303K	Buy	6,460 +720	+13%	+$31.2K	0.23%	79
2020 Q3	$213K	Buy	5,740 +50	+0.9%	+$1.9K	0.18%	81
2020 Q2	$208K	Buy	+5,690	New	+$198K	0.19%	79
2020 Q1	–	Sell	-5,840	Closed	-$298K	–	89
2019 Q4	$298K	Buy	5,840 +9	+0.2%	+$434	0.24%	85
2019 Q3	$275K	Hold	5,831	–	–	0.23%	86
2019 Q2	$290K	Buy	5,831 +231	+4%	+$10.9K	0.25%	85
2019 Q1	$238K	Hold	5,600	–	–	0.22%	84
2018 Q4	$230K	Buy	+5,600	New	+$240K	0.23%	81

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brooks Moore & Associates's MET Position: Q1 2023 in Review

Brooks Moore & Associates sold out of MetLife (MET) in Q1 2023, closing a stake of 6,460 shares — an estimated $468K sold.

Brooks Moore & Associates first reported a position in MET in Q4 2018 and held it in 16 quarters. The position peaked at $468K in Q4 2022. 1,213 funds tracked by Wall St. Rank hold MET as of Q1 2023.

Brooks Moore & Associates reported no remaining MetLife position as of Q1 2023 after selling out during the quarter.
Brooks Moore & Associates sold 6,460 MetLife shares in Q1 2023, an estimated $468K.
Brooks Moore & Associates first reported a position in MetLife in Q4 2018 and held it in 16 quarters.
Brooks Moore & Associates's MetLife position peaked at $468K in Q4 2022.
1,213 funds tracked by Wall St. Rank held MetLife as of Q1 2023.

Based on Brooks Moore & Associates's 13F filing for Q1 2023, filed 15 May 2023.